FP102
4295N
Dr.Chandra lakshmi C
| Membership No | Author Name | Mobile | |
|---|---|---|---|
| 4295N | Dr.Chandra lakshmi C | chandumay1@yahoo.com | 9871554298 |
Medical Retina
FOUR-WEEK RENAL SAFETY PROFILE OF INTRAVITREAL RAZUMAB IN MACULAR EDEMA: A PROSPECTIVE PILOT STUDY
PURPOSE:To evaluate the effect of the intravitreal Anti-VEGF(RAZUMAB)on renal parameters of treatment-naïve eyes for macular edema.METHODS:A cross-sectional prospective study of n= 15 eyes receiving intravitreal injection for the treatment of macular edema was evaluated.The demographics,renal parameters such as S.urea,S.creatinine,Urine PCR(protein creatine ratio)were assessed at baseline and 4weeks post injection.Visual acuity(BCVA),Central macular thickness(CMT)and BP values(pre- and post-injections) were recorded.BCVA,change in CMT and renal parameters pre and post injections were analyzed.RESULTS:Mean Age was 56years.DME(Diabetic macular edema)in 60%and Retinal vein related macular edema in 40%.The CMT pre and post injections were 411 and 326 μm respectively.CMT was statistically significant with p=0.0001.The change in e-GFR was not statistically significant with p=0.58(p >0.05).CONCLUSIONS:Intravitreal Razumab did not significantly cause any change in renal parameters in our study
| Membership No | Author Name | Mobile | |
|---|---|---|---|
| 1385 | Dr.Prathibha S | prathibhas@rediffmail.com | 9986485551 |
| 2860 | Dr.REETHA B T | reethab11@gmail.com | 9900958888 |
| 2231 | Dr.Shilpa S Reddy | drshilpa68@gmail.com | 9538712766 |